Posts Tagged: fda


Illicit pharmaceutical drug sales find a home on Twitter

Twitter’s popularity has not only benefited the legitimate side of the pharmaceutical industry. A study released in December, supported by both the Global Health Policy Institute …
By Steve Brachmann 2 days ago 0

Phase 3 trial starts for treatment for peanut allergy

It is estimated that more than 30 million people in the United States and Europe have a food allergy, and more than five million people in the United …
By Gene Quinn 28 days ago 3

Tech News Roundup: Bezos and Musk Square Off, LED ‘Li-Fi’ Internet and VTech Data Breach

Our latest Tech Round-Up here on IPWatchdog takes a brief glance at many of the stories which have caught our attention in recent days. As he often …
By Steve Brachmann 2 months ago 0

The future of agricultural pest control is biopesticides, IoT insect monitoring systems

The Internet of Things has been lauded as a potential boon for crop production, including pest control. Automated IoT pest control systems have been developed by Spensa …
By Steve Brachmann 4 months ago 0

Pharmaceutical greed makes Martin Shkreli public enemy #1

On August 10th, the rights to sell Daraprim were bought from Impax Laboratories Inc. (NASDAQ:IPXL) of Hayward, CA, by Turing Pharmaceuticals, a privately held company with …
By Steve Brachmann 5 months ago 11

Hybrigenics gets Orphan Drug designation for the treatment of Acute Myeloid Leukemia

Hybrigenics (ALHYG), a French bio-pharmaceutical company with a focus on research and development of new treatments against proliferative diseases, has announced that the Food and Drug Administration (…
By Gene Quinn 6 months ago 0

Federal Circuit Review – Issue 61 – July 31, 2015

Amgen filed a biologics license application (“BLA”) and obtained FDA approval for its filgrastim product, Neupogen. Sandoz subsequently filed an abbreviated BLA (“aBLA”) under 42 U.S.C. § 262(…

When Lives Depend on Tech Transfer

Nothing clarified the stakes in orphan drug development like hearing Ron Bartek describe how after 16 years a promising treatment for his son’s disease finally emerged with …
By Joseph Allen 1 year ago 0

SCOTUS: FDA Regulations No Bar to Lanham Act Claims

The Supreme Court reversed a decision from the Ninth Circuit that held that within the realm of labeling for food and beverages, a Lanham Act claim asserting …
By Gene Quinn 2 years ago 0

Pharma Update: News for April 2014

What follows below is a review of some of the pharma news stories that caught my attention during the month of April 2014. Supreme Court Denies Teva's Request …
By Gene Quinn 2 years ago 0

Mylan’s Prevails in Perforomist® Patent Dispute

Mylan Inc. (NASDAQ: MYL) recently prevailed in the United States District Court for the Northern District of West Virginia in a patent dispute involving Perforomist® (formoterol fumarate) …
By IPWatchdog 2 years ago 0

Seven IP Cases Slated on Supreme Court Oral Argument Calendar

The Court will hear oral argument as follows: on February 26, in two cases on granting (Octane Fitness) and reviewing (Highmark) attorneys’ fee awards; on March 31, in a …
By AIPLA 2 years ago 0